Comparison of Levothyroxine Formulation in Hypothyroid Patients With

Status Terminated

Clinical Trial Summary

The purpose of this study is to test a liquid levothyroxine formula and examine if it will lead to improvement in management of thyroid function and if it improves hypothyroid symptoms that patients experience.

Clinical Trial Description

Patients who require enteral nutrition through an enteral feeding tube and have hypothyroidism often struggle with the management of hypothyroidism. Hypothyroidism usually requires lifelong treatment except in some cases. It has been clinically observed the traditional management of hypothyroidism is to crush the tablet and administer the medical through the enteral nutrition tube and hold the feeds for one hour. However, management of the hormonal profile has been noted to have variable results with this method. Limited data is available about the effectiveness of levothyroxine liquid formulation in outpatients' dependent on enteral feeding tubes for administration. Therefore, we propose a study to assess if daily treatment of, Tirosint-SOL (liquid levothyroxine, IBSA pharma Inc.), will improve thyroid function tests in individuals requiring enteral nutrition and are hypothyroid in a prospective, randomized study in a population requiring enteral nutrition. We hypothesize that Tirosint-SOL will lead to improvement in management in their thyroid function tests resulting in possible improvement in hypothyroid symptoms experienced by the patients. This will be a randomized controlled trial. The study will be conducted in patients who have uncontrolled hypothyroidism on levothyroxine therapy. These patients will also be dependent on enteral nutrition and medication administration through the gastrostomy tube. The participants will be followed at UCLA Enteral Nutrition Clinic. Participants will be randomized 1:1 to either continue current management with the same dose or to dose equivalent liquid levothyroxine. At baseline (week 0) and week 6-8, TSH and thyroid function tests will be performed. In addition, medical history and physical, body weight, HR, blood pressure, nutritional intake by a registered dietitian will be done at each visit. ;

Study Design

Related Conditions & MeSH terms

Hypothyroidism

Clinical Trial Details

NCT number	NCT04878614
Study type	Interventional
Source	University of California, Los Angeles
Contact
Status	Terminated
Phase	Phase 4
Start date	May 5, 2021
Completion date	February 16, 2022

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05975866` - The Effects of an Anti-inflammatory Diet With or Without Curcumin Supplementation on Anthropometric Measurements, Concentrations of Thyroid Hormones, Anti-TPO, and Systemic Inflammation in Plasma and NFK-B in Peripheral Blood Mononuclear Cells in Patients With Hashimato	N/A
Not yet recruiting	`NCT05334771` - Early Detection of Endolymphatic Hydrops in Hypothyroid Patients
Withdrawn	`NCT01707056` - The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma	N/A
Completed	`NCT00094237` - Subclinical Thyroid Dysfunction and Risk of Myocardial Infarction and Stroke	N/A
Recruiting	`NCT06015620` - Comorbidities Resolution After MGB Surgery and Change in Body Composition
Completed	`NCT03612908` - TSHβX1 and D2 THR92ALA in Pregnancy
Completed	`NCT04782856` - Energy Metabolism in Thyroidectomized Patients	Phase 2
Completed	`NCT01921452` - Study to Verify Clinical Utility of Point-of-Care (POC) Thyroid Stimulating Hormone (TSH) Test Kits as Compared to Third Generation TSH Test Kit	Phase 4
Completed	`NCT01197183` - Observational Study With Prospective and/or Retrospective Follow-up, Without Modifying Patient Treatment and Follow-up Practices for the Initial Treatment of Hypothyroidism in France	N/A
Recruiting	`NCT05247476` - Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients.	Phase 4
Recruiting	`NCT03754621` - Upper Limit for TSH of First and Second Trimester Pregnancy in Turkey
Completed	`NCT02959827` - Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States
Completed	`NCT04124705` - A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants	Phase 2
Withdrawn	`NCT02577367` - Mean Percentage of Levothyroxine Dosage Increase in Patients With Hypothyroidism Started on Enteral Feeding	Phase 4
Completed	`NCT04098991` - Improving White Matter Integrity With Thyroid Hormone
Not yet recruiting	`NCT03257566` - Hypothyroidism in Patients With Type 1 Diabetes	N/A
Terminated	`NCT02567877` - Is Levothyroxine Alone Adequate Thyroid Hormone Replacement?
Completed	`NCT02280330` - Iodine Status of Preschoolers Given Micronutrient Powder for 6 Months	Phase 4
Completed	`NCT00403390` - Generic vs. Name-Brand Levothyroxine	N/A
Not yet recruiting	`NCT06096454` - Effect of Life Style Modification and Metformin on Hypothyroidism With Insulin Resistance	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Comparison of Levothyroxine Formulation in Hypothyroid Patients With Enteral Feeding

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms